Details for Patent: 7,300,931
✉ Email this page to a colleague
Which drugs does patent 7,300,931 protect, and when does it expire?
Patent 7,300,931 protects KLISYRI and is included in one NDA.
This patent has forty-one patent family members in twenty-one countries.
Summary for Patent: 7,300,931
Title: | Compositions for treating cell proliferation disorders |
Abstract: | The invention relates to compounds and methods for treating cell proliferation disorders. |
Inventor(s): | Hangauer, Jr.; David G. (East Amherst, NY) |
Assignee: | Kinex Pharmaceuticals, LLC (Buffalo, NY) |
Application Number: | 11/321,419 |
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 7,300,931
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Almirall | KLISYRI | tirbanibulin | OINTMENT;TOPICAL | 213189-001 | Dec 14, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,300,931
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | E544748 | ⤷ Try a Trial | |||
Australia | 2005321966 | ⤷ Try a Trial | |||
Australia | 2007265373 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |